同位素2011，Vol.24Issue(z1)：36-44,9.
近年来211At放射性药物研究的新进展
New Progress of 211At Labelled Radiopharmaceuticals Recently
刘宁 1杨远友 1廖家莉 1金建南1
作者信息
- 1. 四川大学原子核科学技术研究所 辐射物理及技术教育部重点实验室,四川成都610064
- 折叠
摘要
Abstract
211At, produced by cyclontron, is a promising radioisotope for tumor targeted radiotherapy due to its favorable radiobiological characteristics and cytotoxicity. The progress of radiopharmaceuticals labeled with 211 At were reviewed with 50 references in recent years, including the preparation of 211At, the experimental and clinical research of labeled compounds, labeling methods, etc. Additionally, its situation, problems and prospect were discussed.关键词
211At/放射性药物/进展Key words
211At/radiopharmaceutica/progress分类
化学化工引用本文复制引用
刘宁,杨远友,廖家莉,金建南..近年来211At放射性药物研究的新进展[J].同位素,2011,24(z1):36-44,9.
